Characterization of putative virulence factors of Serratia marcescens strain SEN for pathogenesis in Spodoptera litura.

Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA.

How Patients View Lung Cancer Screening. The Role of Uncertainty in Medical Decision Making.

DNA-based immunotherapy for HPV-associated head and neck cancer.

Fine tuning chloroplast movements through physical interactions between phototropins.

Imaging for the Pretreatment Staging of Small cell Lung Cancer: A Systematic Review.

Immunotherapy for head and neck cancer: latest developments and clinical potential.

http://www.ncbi.nlm.nih.gov/books/NBK362066/

Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy.

Biomarkers to enhance accuracy and precision of prediction of short-term and long-term outcome after spontaneous intracerebral haemorrhage: a study protocol for a prospective cohort study.

Arabidopsis PCNAs form complexes with selected D-type cyclins.

A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511).

Pembrolizumab for the treatment of non-small-cell lung cancer.

Identification of Quorum-Sensing Inhibitors Disrupting Signaling between Rgg and Short Hydrophobic Peptides in Streptococci.

Rare Complex Mutational Profile in an ALK Inhibitor-resistant Non-small Cell Lung Cancer.